The objective of this Dialogue was to discuss options for strengthening developing countries´ and LDCs´ local capacities in the pharmaceutical sector, including through investment, IPRs, and trade.

Emphasis was put on innovative approaches to the use of TRIPS flexibilities, on development objectives and on the feasibility of national approaches taken by various countries in line with their international commitments.